Advancing the Science

Mayo Clinic Medical Science Blog – an eclectic collection of research- and research education-related stories: feature stories, mini news bites, learning opportunities, profiles and more from Mayo Clinic.

Items Tagged ‘hematology’

July 9, 2018

Offering underserved groups access to cutting-edge research

By Kris Schanilec kschanilec

For many patients, clinical trials offer a chance to benefit from promising new treatments that are not available in the doctor’s office. Yet not all people have the same access to these opportunities. Groups such as racial minorities, older individuals, and those with low income are less likely than others to participate in clinical trials, […]

View full entry

Tags: biobank, blood cancer, Carmen Radecki Breitkopf, clinical trials, community engagement, Gerardo Colon-Otero, health disparities, hematology, HPV, lymphoma, Mayo Clinic Cancer Center


April 11, 2018

Training the next generation of clinician scientists

By Elizabeth Zimmermann elizabethzimmermann

In the Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery education focuses on integrating programs and opportunities to deliver training to current and future health care providers. Within Education , the Kern Health Care Delivery Scholars Program is training and mentoring the next generation of clinically trained doctoral-level fellows and […]

View full entry

Tags: Adam Schwartz, Ali Duarte-Garcia, Center for the Science of Health Care Delivery, Dorin Colibaseanu, education, Erin Barreto, hematology, Kern Health Care Delivery Scholars, Nandita Khera, orthopedics, pharmacy, Rahma Warsame


October 25, 2017

Unnecessary Test for Venous Thromboembolism: Inefficient and Costly

By gmchiri gmchiri

A recent Mayo Clinic study has found that many U.S. health care providers are habitually ordering a mostly unnecessary and quite expensive genetic test to identify a patient’s hereditary risk of venous thromboembolism.

View full entry

Tags: genetics, hematology, OptumLabs


February 16, 2017

Drug combo safe for diffuse large B-cell lymphoma

By Nicole Brudos Ferrara nicoleferrara

  Drugs targeting the P13K-mTOR pathway add benefit when combined with standard R-CHOP therapy.   The drug everolimus can be safely combined with R-CHOP for new, untreated diffuse large B-cell lymphoma, according to the results of a pilot study by Mayo Clinic researchers. The researchers published their study findings in the July 2016 issue of […]

View full entry

Tags: cancer, clinical trials, Forefront, hematology, lymphoma, Mayo Clinic Cancer Center, non-Hodgkin lymphoma, Patrick Johnston


Contact Us · Privacy Policy